Clinical and Translational Allergy (Oct 2018)
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
- J. Bousquet,
- S. Arnavielhe,
- A. Bedbrook,
- M. Bewick,
- D. Laune,
- E. Mathieu-Dupas,
- R. Murray,
- G. L. Onorato,
- J. L. Pépin,
- R. Picard,
- F. Portejoie,
- E. Costa,
- J. Fonseca,
- O. Lourenço,
- M. Morais-Almeida,
- A. Todo-Bom,
- A. A. Cruz,
- J. da Silva,
- F. S. Serpa,
- M. Illario,
- E. Menditto,
- L. Cecchi,
- R. Monti,
- L. Napoli,
- M. T. Ventura,
- G. De Feo,
- D. Larenas-Linnemann,
- M. Fuentes Perez,
- Y. R. Huerta Villabolos,
- D. Rivero-Yeverino,
- E. Rodriguez-Zagal,
- F. Amat,
- I. Annesi-Maesano,
- I. Bosse,
- P. Demoly,
- P. Devillier,
- J. F. Fontaine,
- J. Just,
- T. P. Kuna,
- B. Samolinski,
- A. Valiulis,
- R. Emuzyte,
- V. Kvedariene,
- D. Ryan,
- A. Sheikh,
- P. Schmidt-Grendelmeier,
- L. Klimek,
- O. Pfaar,
- K. C. Bergmann,
- R. Mösges,
- T. Zuberbier,
- R. E. Roller-Wirnsberger,
- P. Tomazic,
- W. J. Fokkens,
- N. H. Chavannes,
- S. Reitsma,
- J. M. Anto,
- V. Cardona,
- T. Dedeu,
- J. Mullol,
- T. Haahtela,
- J. Salimäki,
- S. Toppila-Salmi,
- E. Valovirta,
- B. Gemicioğlu,
- A. Yorgancioglu,
- N. Papadopoulos,
- E. P. Prokopakis,
- S. Bosnic-Anticevich,
- R. O’Hehir,
- J. C. Ivancevich,
- H. Neffen,
- E. Zernotti,
- I. Kull,
- E. Melen,
- M. Wickman,
- C. Bachert,
- P. Hellings,
- S. Palkonen,
- C. Bindslev-Jensen,
- E. Eller,
- S. Waserman,
- M. Sova,
- G. De Vries,
- M. van Eerd,
- I. Agache,
- T. Casale,
- M. Dykewickz,
- R. N. Naclerio,
- Y. Okamoto,
- D. V. Wallace,
- MASK study group
Affiliations
- J. Bousquet
- MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve
- S. Arnavielhe
- KYomed-INNOV
- A. Bedbrook
- MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve
- M. Bewick
- iQ4U Consultants Ltd
- D. Laune
- KYomed-INNOV
- E. Mathieu-Dupas
- KYomed-INNOV
- R. Murray
- MedScript Ltd
- G. L. Onorato
- MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve
- J. L. Pépin
- Laboratoire HP2, Grenoble, INSERM, U1042, Université Grenoble Alpes
- R. Picard
- Conseil Général de l’Economie Ministère de l’Economie, de l’Industrie et du Numérique
- F. Portejoie
- MACVIA-France, Fondation Partenariale FMC VIA-LR, CHRU Arnaud de Villeneuve
- E. Costa
- UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing, University of Porto (Porto4Ageing)
- J. Fonseca
- Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto
- O. Lourenço
- Faculty of Health Sciences and CICS – UBI, Health Sciences Research Centre, University of Beira Interior
- M. Morais-Almeida
- Allergy Center, CUF Descobertas Hospital
- A. Todo-Bom
- Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra
- A. A. Cruz
- ProAR – Nucleo de Excelencia em Asma, Federal University of Bahia
- J. da Silva
- Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC)
- F. S. Serpa
- Asthma Reference Center, Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria
- M. Illario
- Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET)
- E. Menditto
- CIRFF, Federico II University
- L. Cecchi
- SOS Allergology and Clinical Immunology, USL Toscana Centro
- R. Monti
- Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital
- L. Napoli
- Consortium of Pharmacies and Services COSAFER
- M. T. Ventura
- Unit of Geriatric Immunoallergology, University of Bari Medical School
- G. De Feo
- Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno
- D. Larenas-Linnemann
- Center of Excellence in Asthma and Allergy, Hospital Médica Sur
- M. Fuentes Perez
- Y. R. Huerta Villabolos
- D. Rivero-Yeverino
- E. Rodriguez-Zagal
- F. Amat
- Allergology Department, Centre de l’Asthme et des Allergies Hôpital d’Enfants Armand-Trousseau (APHP)
- I. Annesi-Maesano
- Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, UPMC Sorbonne Université, Medical School Saint Antoine
- I. Bosse
- P. Demoly
- Department of Respiratory Diseases, Montpellier University Hospital
- P. Devillier
- UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay
- J. F. Fontaine
- J. Just
- Allergology Department, Centre de l’Asthme et des Allergies Hôpital d’Enfants Armand-Trousseau (APHP)
- T. P. Kuna
- Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz
- B. Samolinski
- Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw
- A. Valiulis
- Clinic of Children’s Diseases, and Institute of Health Sciences Department of Public Health, Vilnius University Institute of Clinical Medicine
- R. Emuzyte
- Clinic of Children’s Diseases, Faculty of Medicine, Vilnius University
- V. Kvedariene
- Faculty of Medicine, Vilnius University
- D. Ryan
- Woodbrook Medical Centre
- A. Sheikh
- Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh
- P. Schmidt-Grendelmeier
- Allergy Unit, Department of Dermatology, University Hospital of Zurich
- L. Klimek
- Center for Rhinology and Allergology
- O. Pfaar
- Center for Rhinology and Allergology
- K. C. Bergmann
- Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin
- R. Mösges
- Institute of Medical Statistics, and Computational Biology, Medical Faculty, University of Cologne
- T. Zuberbier
- Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin
- R. E. Roller-Wirnsberger
- Department of Internal Medicine, Medical University of Graz
- P. Tomazic
- Department of ENT, Medical University of Graz
- W. J. Fokkens
- Department of Otorhinolaryngology, Academic Medical Centre
- N. H. Chavannes
- Department of Public Health and Primary Care, Leiden University Medical Center
- S. Reitsma
- Department of Otorhinolaryngology, Academic Medical Centre
- J. M. Anto
- ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL)
- V. Cardona
- Allergy Section, Department of Internal Medicine, Hospital Vall ‘dHebron & ARADyAL Research Network
- T. Dedeu
- AQuAS
- J. Mullol
- Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, University of Barcelona
- T. Haahtela
- Skin and Allergy Hospital, Helsinki University Hospital
- J. Salimäki
- Association of Finnish Pharmacists
- S. Toppila-Salmi
- Skin and Allergy Hospital, Helsinki University Hospital
- E. Valovirta
- Department of Lung Diseases and Clinical Immunology, University of Turku
- B. Gemicioğlu
- Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University
- A. Yorgancioglu
- Department of Pulmonary Diseases, Faculty of Medicine, Celal Bayar University
- N. Papadopoulos
- Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children’s Hospital, University of Manchester
- E. P. Prokopakis
- Department of Otorhinolaryngology, University of Crete School of Medicine
- S. Bosnic-Anticevich
- Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District
- R. O’Hehir
- Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University
- J. C. Ivancevich
- Servicio de Alergia e Immunologia, Clinica Santa Isabel
- H. Neffen
- Director of Center of Allergy, Immunology and Respiratory Diseases, Santa Fe, Argentina Center for Allergy and Immunology
- E. Zernotti
- Universidad Católica de Córdoba
- I. Kull
- Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset
- E. Melen
- Sachs’ Children and Youth Hospital, Södersjukhuset
- M. Wickman
- Centre for Clinical Research Sörmland, Uppsala University
- C. Bachert
- Upper Airways Research Laboratory, ENT Department, Ghent University Hospital
- P. Hellings
- Euforea
- S. Palkonen
- EFA European Federation of Allergy and Airways Diseases Patients’ Associations
- C. Bindslev-Jensen
- Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA)
- E. Eller
- Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA)
- S. Waserman
- Department of Medicine, Clinical Immunology and Allergy, McMaster University
- M. Sova
- University Hospital Olomouc
- G. De Vries
- Peercode BV
- M. van Eerd
- Peercode BV
- I. Agache
- Faculty of Medicine, Transylvania University
- T. Casale
- Division of Allergy/Immunology, University of South Florida
- M. Dykewickz
- Section of Allergy and Immunology, Saint Louis University School of Medicine
- R. N. Naclerio
- Johns Hopkins School of Medicine
- Y. Okamoto
- Department of Otorhinolaryngology, Chiba University Hospital
- D. V. Wallace
- Nova Southeastern University
- MASK study group
- DOI
- https://doi.org/10.1186/s13601-018-0227-6
- Journal volume & issue
-
Vol. 8,
no. 1
pp. 1 – 21
Abstract
Abstract mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.
Keywords
